Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 195Myeloid 141Sarcoma 99Gastrointestinal 84Lymphoid 49CNS 23Thoracic 19Dermatologic 16Genitourinary 15Other solid neoplasm 11Gynecologic 11Breast 10Tumor-Agnostic 7Head & Neck 7Plasma cell 4Endocrine 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Imatinib Mesylate × Endocrine × Clear all
NCT03469011 2025-06-27

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

AHS Cancer Control Alberta

Phase 1 Terminated
14 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT00115739 2014-04-21

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Terminated
11 enrolled 10 charts
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡